SEC Form 4 research
| Issuer | Tokai Pharmaceuticals Inc |
|---|---|
| Tickers | TKAI, NVUS, ELDN |
| Reporting owners | 56 |
| Officers and directors | 16 |
| Last public filing | 2026-08-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-04 | 2026-07-31 | Gros David-Alexandre C | A | 354,454 | $0 | Not reported |
| 2026-08-04 | 2026-07-31 | Perrin Steven | A | 152,353 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.